Inspiring women in science, part IV

Christiane Nüsslein-Volhard was born in Germany in 1942. She and Eric Wieschaus identified many of the genes that control the embryonic development of Drosophila. The figure above is of a wildtype fruitfly embryo, and those homozygous for mutations in Krüppel, hunchback, and knirps, from “Mutations affecting segment number and polarity in Drosophila”, Nature, 1980; 287:795-801. She is also associated with the discovery of Toll, which led to the identification of toll-like receptors. She received the Nobel Prize in Physiology or Medicine in 1995 for her discoveries into how complex multicellular organisms develop from single cells. The quote below is from her 2006 book, “Coming to Life: How Genes Drive Development”.

Clearly, biology is the most interesting of the sciences.

Inspiring women in science, part III

Elizabeth Blackburn was born in Australia in 1948. She and Carol Greider discovered telomerase. Telomerase is an enzyme that loss of important DNA from chromosome ends by adding extra bits of DNA to the end of strands, and plays a role in aging and cancer. The figure above is DNA from a telomerase enzyme reaction, from “Identification of a specific telomere terminal transferase activity in Tetrahymena extracts”, published in Cell, 1985; 43:405–413. She received the Nobel Prize in 2009. When questioned about the large number of women working on telomeres, she replied that “it’s fairly close to the biological ratio of men and women. It’s all the other fields that are aberrant.”

Inspiring women in science, part II

Lise Meitner was born in Austria in 1879. She and Otto Hahn discovered the first long-lived isotope of protactinium and articulated how the nucleus of an atom could be split into smaller parts in their paper “Disintegration of Uranium by Neutrons: A New Type of Nuclear Reaction” published in Nature in 1939. The figure above illustrates fission fragments in an uranium-lined ionization chamber connected to an oscillograph. The large pulses were caused by ionization bursts of fast moving nuclei from uranium bombarded by neutrons. Element 109, meitnerium, is named in her honour.

To me, this quote counters the argument that theologists often direct to athiests - that to not believe in the supernatural is to live in a world that is flat and dull. No! Far from it! To pull away the curtains of silly supernatural explanations is to allow yourself to peak at reality, a truth that is far more awe-inspiring and magestic then anything that could have been invented by primitive desert-dwellers. 

Inspiring women in science, part I

Rather than directly address the ridiculous sexist comments by Tim Hunt, I thought I would post a series of quotes by inspiring female scientists. These quotes adorn my office, and were a gift from my wife - who is an inspiring scientist herself.

Françoise Barré-Sinoussi was born in France in 1947. She was part of the team that discovered and identified HIV as the cause of AIDS in 1983. The figure above is of viruses budding from lymphocytes, from “Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)”, Science, 1983; 868-871. She also identified important factors contributing to mother-to-child transmission of HIV. She received the Nobel Prize in 2008.

To me this quote encapsulates the inspiring nature of science. When you look around yourself, science is everything that has transformed life from being nasty, brutish and short, to one where many of us have love, luxury and peace. This transformation can be extended to everyone if only we use science and evidence-based decision-making.

PhD graduation

Congratulations to Dina Danso-Abeam who just graduated from her PhD in the laboratory!

Lei Tian wins prestigious research award

Congratulations to Autoimmune Genetics Laboratory student Lei Tian, who just won the 2013 National Award for Outstanding Self-financed Chinese Students Study Abroad by the China Scholarship Council. The prize was granted for her doctoral research on regulatory T cells and diabetes development.

Sex discrimination in academia - Flanders edition

This is a very interesting article about the sex discrimination in academia in Flanders. In Flanders only 11% of professorships are held by women, making Flanders one of the worst regions in the EU for sex equality in academia. The "glass ceiling index" has been calculated for Belgium as a whole at 2.25, meaning that it is 2.25 times harder for a woman to get a professorship than a man - again, almost the worst value in the EU. 

As the largest and oldest university in Belgium, KU Leuven bears a great deal of responsibility for this situation. Despite 600 years of history, KU Leuven has never had a female Rector. Even in Biomedical Sciences, a field dominated by women at the graduate level, only 25% of professors are female, and the situation gets much worse in the traditionally male-dominated areas. Worst of all, despite performing so badly in this area, the university has no systematic policy directives to even start to correct the problem. To try to compete in an international high performance field while ignoring half of the available talent is absurd, to say the least.

Is this a cut-and-dried case of blatant sexism? In consideration, I would suggest probably not. The effect is certainly sexist, women are not getting opportunities given to men. The primary cause, however, is probably not so much sexism as conservatism. Marc Hooghe (KU Leuven) says "What Belgian universities still have is this kind of closed-shop attitude", where old white men pick people who look like themselves for the next generation academia. Alison Woodward (VUB) points out "In Belgium, no one knows about two-thirds of the jobs. How did that guy get it?" and notes that this old boys' club excludes not only women, but also foreigners and ethnic minorities. So rather than just trying to improve parental issues*, perhaps Flemish universities should instead focus on open merit-based hiring. If women are just given a truly equal chance, I have no doubt that soon they will hold at least 50% of positions.

* One of my pet peeves, as the data showing that having a child is detrimental to women but not men is not a cause of discrimination - it is an effect of discrimination. If men actually did half the parenting, then parental issues would have absolutely no effect on sex equality. By all means, try to make child raising easier, just don't think that this alone creates sex equality.

Women in Molecular Immunology

It is easy to discuss equality in science through anecodote. Just by spending most of my waking adult life on university campuses across three continents I am fairly confident in saying that sexual equality is better in biology and medicine than in chemistry or physics, is great at undergraduate level and lagging at professorial level, and is better in Australia than in Belgium. Much better than anecodote, though, is quantitative analysis, which is why I love this website. If you don't publish your research it is a hobby, not science, and a good publication record is the A to Z of career success for a scientist. This website collates data on authorship across time and across disciplines, at a global level, and assesses the participation of women. There are a few caveats: papers are only assessed if they are listed in the JSTOR database, and a gender is only assigned by first name analysis (using the US Social Security database as a reference, so it probably fails for first names not commonly used in the US). Still, it is an absolutely beautiful reference point.

There is an wealth of knowledge in this database, but my interest is in molecular immunology, so how are we performing? Well, the question kind of depends on "compared to what?" In 1991-2010, 29.7% of authors on molecular immunology papers were women. This is an improvement from 1971-1990 (23.9%), and a huge improvement from pre-history (being everything from 1970 and before, at 13.7%). It is also outstanding compared to fields such as mathematics, where women still only account for 10% authors (maths clearly has a problem with women; anyone who says the reverse is kidding themselves). But 29.7% is still a long way from 50%. Even among first authors (typically PhD students or post-docs), only 33.2% of molecular immunology authors were women, and among last authors (typically professors) only a dismal 15.4% were women. 

I've said before what I think the problem is (hint, it is men), but this database gives us a resource to see who is fixing the problem, and how fast, and who is content to live in the stone-age and try to do science with a 50% lobotomy. So many questions arise. Why has virology been more equal than immunology throughout the time period? I would love to see a break-down by country to know if this is a discipline-thing, or is a statistical quirk due to regional differences in sexism correlating by chance with regional differences in research focus.

Oh, and for the trivia-minded, within molecular biology the most equal area of research is heat shock proteins, while the most sexist is prostaglandins. In the entire database, the most female-dominated area of research is gender studies (57.8% female authors), while the most male-dominated area of research is a discipline of mathematics called Riemannian manifolds (99.3% male authors). Check it out.

AIG laboratory members successful at the FWO

This week we received exciting news that the Autoimmune Genetics laboratory had three successful candidates at the FWO, the premier fellowship program in Belgium. 

Dr Stephanie Humblet-Baron won an FWO Post-doctoral Fellowship award to research a new genetic disease caused by a loss of dendritic cells:

In the immune system, dendritic cells (DCs) are a subset of white blood cells that are specialized to activate lymphocytes when a pathogen is present In the absence of DCs, activation of lymphocytes and clearance of infections is impaired.  A new genetic disease has recently been identified where patients have no DCs, and surprisingly not only do they have poor clearance of infections, but they also have a large expansion of myeloid cells in their blood. For this project we have created a mouse model of this disease, which we will use to try to understand the biology of the myeloid expansion and to test potential therapeutics. 

Dr Susan Schlenner won a Pegasus Post-doctoral Fellowship award to move to the laboratory from Harvard. Here she will use novel genetic approaches to understand the biology of regulatory T cells.

Regulatory T cells are an important subset of white blood cells that have the ability to prevent the immune system from attacking components of the body (“autoimmunity”) and from attacking harmless environmental components (“allergy”). In order to exert this function the regulatory T cells need to be educated as to which components are safe and should be protected from immune attack. The location where this occurs is highly controversial as previously there have not been the correct tools to do functional tests. This project aims to generate a sophisticated set of genetically-altered mouse strains to allow measurement of where regulatory T cells are educated, and then to use these mice in models of autoimmunity and allergy. Having more knowledge about the education process of regulatory T cells may allow the future development of therapeutic interventions in those patients where regulatory T cells fail to prevent autoimmunity or allergy.

Dr Lien Van Eyck won an FWO PhD Fellowship, to move from the clinic to the laboratory to study auto-inflammatory diseases.

Blau Syndrome (BS) and Early Onset Sarcoidosis (EOS) are rare monogenic auto-inflammatory diseases characterized by a clinical triad of granulomatous arthritis, uveitis and rash. Extended manifestations with potentially high morbidity have been reported recently. The pathologic hallmark of BS/EOS is the presence of multinucleated giant cell and epithelioid cell granulomas in affected tissues. Both diseases are associated with gain-of-function mutations in the NOD2 gene. NOD2 is a specialised intracellular protein that plays a critical role in the regulation of the host innate immune response through recognising conserved microbial molecular signatures, thus leading to the induction of pro-inflammatory and anti-microbial responses as well as apoptosis. While the genetic basis of BS/EOS has been characterized, the molecular mechanisms by which NOD2 mutations drive granuloma formation and the development of sarcoidosis remain unclear. A better understanding of these mechanisms is of direct relevance for the development of targeted immunotherapies. The present project aims to determine the mechanisms by which NOD2 gain-of-function mutations lead to immunopathology in BS/EOS by developing a murine model with a gain-of-function mutation in NOD2. This model will allow for a full characterization of the immunopathology of NOD2 associated inflammation, and for the unravelling of molecular and cellular mechanisms involved in disease pathogenesis.

FWO post-doctoral fellowship awarded to Bénédicte Cauwe

This week it was announced that Dr Bénédicte Cauwe won an FWO post-doctoral fellowship to perform research in the Autoimmune Genetics Laboratory. Dr Cauwe recently finished her PhD in the laboratory of Professor Ghislain Opdenakker at the Rega Institute and will continue her research on systemic lupus erythematosus at the Autoimmune Genetics Laboratory.